References
[1] Nazha B, Moussaly E, Zaarour M, et al. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World J Gastrointest Surg. 2015;7:370-7.
[2] Tunç S, Cetinkaya A, Duman O. Spectroscopic investigations of the interactions of tramadol hydrochloride and 5-azacytidine drugs with human serum albumin and human hemoglobin proteins. Photochem Photobiol B. 2013;120:59-65.
[3] Eckart A, Struja T, Kutz A, et al. Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study. Am J Med. 2020;133(6):713-22.
[4] Seaton K. Albumin concentration controls cancer. J Natl Med Assoc. 2001;93:490-3.
[5] Rozga J, Piątek T, Małkowski P. Human albumin: old, new, and emerging applications. Ann Transplant. 2013;18:205-17.
[6] Zaher DM, El-Gamal MI, Omar HA, et al. Recent advances with alkaline phosphatase isoenzymes and their inhibitors. Arch Pharm (Weinheim). 2020;353:e2000017.
[7] Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. Nippon Med Sch. 2010;77(1):4-12.
[8] Wu XL. Changes and clinical significance of serum alkaline phosphatase in hyperthyroidism patients before and after treatment [dissertation]. Shanxi Medical University; 2023.
[9] Lowe D, Sanvictores T, Zubair M, et al. Alkaline Phosphatase. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Oct 29.
[10] Magnusson P, Degerblad M, Sääf M, et al. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J Bone Miner Res. 1997;12(2):210-20.
[11] Magnusson P, Sharp CA, Farley JR. Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts. Clin Chim Acta. 2002;325(1-2):59-70.
[12] Jiang Y, Li X, Walt DR. Single-Molecule Analysis Determines Isozymes of Human Alkaline Phosphatase in Serum. Angew Chem Int Ed Engl. 2020;59:18010-5.
[13] Yang J, Chen Y, Wan J, et al. Prognostic value of the C-reactive protein to albumin ratio in patients with stroke: a meta-analysis. Sci Rep. 2025;15(1):21150.
[14] Taş-Aygar G, Ataş H, Gönül M, et al. Importance of the C-Reactive Protein to Albumin Ratio in the Diagnosis and Prognosis of Mycosis Fungoides. Dermatol Pract Concept. 2024;14(2):e2024097.
[15] Kocatürk M, Kocatürk Ö. Assessment of relationship between C-reactive protein to albumin ratio and 90-day mortality in patients with acute ischaemic stroke. Neurol Neurochir Pol. 2019;53(3):205-11.
[16] Seringec Akkececi N, Yildirim Cetin G, Gogebakan H, et al. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis. Med Sci Monit. 2019;25:1401-9.
[17] Fu YJ, Li KZ, Bai JH, et al. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis. Medicine (Baltimore). 2019;98(48):e18219.
[18] Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31(2):130-6.
[19] Chan AW, Kumada T, Toyoda H, et al. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma. Dis Markers. 2015;2015:564057.
[20] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality world-wide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
[21] Zhang X, Xin Y, Chen Y, et al. Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis. Sci Rep. 2023;13(1):1808.
[22] Li H, Wang L, Chen L, et al. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation. Cancer (Basel). 2020;11(8):2171-80.
[23] Yousif WI, Bakosh MF. Prognostic Impact of Initial Laboratory-based Scores for Hepatocellular Carcinoma Patients: A Retro-spective Study. Clin Exp Hepatol. 2025;15(6):102604.
[24] Li Q, Lyu Z, Wang L, et al. Albumin-to-Alkaline Phosphatase Ratio Associates with Good Prognosis of Hepatitis B Virus-Positive HCC Patients. Onco Targets Ther. 2020;13:2377-84.
[25] Zhang F, Lu SX, Hu KS, et al. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy. Int J Hyperthermia. 2021;38(1):1-10.
[26] Cai X, Chen Z, Chen J, et al. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies. Cancer (Basel). 2018;9(1):189-97.
[27] Bertuccio P, Turati F, Carioli G, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017;67(2):302-9.
[28] Greten TF, Schwabe R, Bardeesy N, et al. Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(6):349-65.
[29] Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215-29.
[30] Li H, Li J, Wang J, et al. Assessment of Liver Function for Evaluation of Long-Term Outcomes of Intrahepatic Cholangiocarci-noma: A Multi-Institutional Analysis of 620 Patients. Front Oncol. 2020;10:525.
[31] Xiong JP, Long JY, Xu WY, et al. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholan-giocarcinoma patients after surgery. World J Gastrointest Oncol. 2019;11(1):39-47.
[32] Zhang F, Lu S, Tian M, et al. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepa-tocellular and Cholangiocarcinoma. Cancer (Basel). 2020;11(17):5177-86.
[33] Wenzel P, von Figura G. Diagnostik und Therapie des Pankreaskarzinoms [Diagnostics and therapy of pancreatic carcinoma]. Dtsch Med Wochenschr. 2021;146(4):246-52.
[34] Zhang K, Dong S, Jing YH, et al. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis. BMC Cancer. 2020;20(1):541.
[35] Haksoyler V, Topkan E. Prognostic Utility of Prechemoradiotherapy Albumin-to-Alkaline Phosphatase Ratio in Unresectable Locally Advanced Pancreatic Carcinoma Patients. Gastroenterol Res Pract. 2021;2021:6647145.
[36] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
[37] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63.
[38] Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10-45.
[39] Ness RM, Llor X, Abbass MA, et al. NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024. J Natl Compr Canc Netw. 2024;22(7):438-46.